Background/Aims: In this study, it was aimed to investigate the effect of 6-week treatment on quality of life in 4-17-year-old children with functional constipation. Materials and Methods: The children 4-17 years old diagnosed as functional constipation according to Rome IV criteria, between June and December 2018 were included in the study. KINDL scales were applied to patients and their parents before starting treatment for 6 weeks and after the end of the treatment. Results: The study was completed with 42 patients. The majority of the patients (54,8%) were female cases and the general part of them (45,2%) were between 4-6 years old. The age at onset of constipation was found to be 5,19±3,658 years. Total KINDL scores of both children and parents were lower before the treatment. Significant improvement was observed in the symptoms of constipation after 6 weeks of treatment. There was a statistically significant (p<0,05) increase in children’s subgroup and total KINDL scores after treatment. Parental subgroup and total KINDL scores also showed a statistically significant (p0,25) Conclusion: A significant increase was observed in all areas of life quality and total score in children with functional constipation after a regular treatment. We think that the treatment of children with functional constipation will significantly improve their quality of life
Background/Aim: In the coronavirus disease 2019 (COVID-19) pandemic, which has been affecting the world for the last 2 years, pulmonary, cardiovascular, and neurological adverse effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported. These negative influences entail a risk for fetal progress. In this study, by performing a detailed clinical evaluation, postnatal ultrasonography, and echocardiography, we aimed to investigate potential neurological and cardiac complications of newborns born to pregnant women infected with COVID-19. Methods: This prospective and cross-sectional study was conducted between January and July 2021. Newborn infants (0–28 days postpartum) born to mothers with proven COVID-19 infection by positive RT-PCR test during pregnancy were enrolled. Fetal cardiac development was evaluated by a pediatric cardiologist with an echocardiographic examination. Fetal neurologic evaluation was performed by a pediatric neurologist using both neurologic examination and transfontanelle ultrasonography (TFUS). Infants were reevaluated every 2 months until 6 months of age. Results: Thirty-three female and 32 male infants born to 64 pregnant women, one being a twin birth, were included in the study. Seven women developed COVID-19 infection in the first trimester, 11 in the second trimester, and 46 in the third trimester. Neurological examination and TFUS were normal in all newborns except one with microcephaly. The etiologic cause could not be detected in this infant, and his neurodevelopment was normal in the follow-up. The cardiac examination did not reveal any significant disorders. Eleven infants failed the standard “Auditory Brainstem Response” (ABR) hearing screening test, so a second test was performed. Only two infants required further investigation after the second test. Conclusion: We did not observe any neurologic and cardiologic teratogenic effects associated with COVID-19 infection during pregnancy.
Background/Aim: Transient tachypnea of the newborn (TTN) is mostly a benign and self-limiting common physiological disorder. Certain factors, such as elective cesarean section (CS) not preceded by spontaneous labor, delivery before 39 gestational weeks, and perinatal asphyxia, interfere with the fetal–neonatal transition. In our study, we aimed to review the results of hospitalized newborns who receive a diagnosis of TTN and investigate the possible relationship between the implementation of labor induction and the occurrence of this disorder. Methods: This study used a case-control study design. We scanned the hospital records of 156 term newborns hospitalized between January 2017 and January 2018 who received a diagnosis of TTN and who did not have any additional fetal and/or maternal risk factors. Demographic features, mode of delivery, and implementation of labor induction in vaginal deliveries were recorded and compared to the data from 150 healthy term infants. Infants were then split into two groups according to their type of labor induction, and a separate subgroup analysis was performed in terms of the risk of TTN development. Results: The incidence of TTN was 2.9% in vaginal deliveries and 8.5% in CSs. Differences between groups regarding gestational age, birth weights, gender, elective induction in vaginal deliveries, interventions in the delivery room, and types of intervention were found (P<0.05). The risk of developing TTN was 2.5 times higher in the induction group compared to those who did not receive induction but still developed TTN (P<0.001). Also, the risk was significantly higher in the induction group compared to those who did not receive induction and did not develop TTN (P<0.001). After applying a logistic regression analysis, labor induction (odds ratio: 1.005; 95% confidence interval: 1.003–1.008, P<0.001) was found to be an independent significant risk factor for developing TTN. Conclusions: This study indicates that infants born via electively induced vaginal delivery had significantly higher rates of TTN. Therefore, elective labor induction can be added as a new risk factor for TTN development. In our opinion, labor induction without valid medical and obstetric indications should be avoided due to maternal and fetal complications.
Background/Objectives: Biphasic reactions are an important consideration during post-treatment observation of children with anaphylaxis; however, real-world pediatric data on observation practices and the timing of these reactions remain limited. This study aimed to describe the clinical characteristics, management practices, observation duration, and occurrence of biphasic reactions among children presenting with anaphylaxis to a tertiary pediatric emergency department (PED). Methods: This single-center retrospective observational study included children aged 0–18 years who presented with anaphylaxis to a tertiary PED between January 2014 and December 2024. Potential cases identified through ICD-10 codes and PED intramuscular adrenaline administration records were reviewed to confirm the diagnosis according to established criteria. Demographic and clinical characteristics, suspected triggers, treatments, observation duration, and biphasic reactions were evaluated. Results: Seventy anaphylaxis episodes in 68 patients were analyzed. The median age was 93.5 months (IQR, 50–156). Food (32.9%) and insect stings (28.6%) were the most common suspected triggers, followed by drug/vaccine-related triggers (18.6%) and allergen immunotherapy (11.4%). Adrenaline was administered in 94.3% of episodes, and intravenous fluid therapy in 50.0%. Central nervous system involvement and age-adjusted hypotension were more frequent among episodes receiving intravenous fluid therapy (p = 0.004 and p < 0.001, respectively). The median PED observation duration was 5.5 h (IQR, 2–8). Biphasic reactions occurred in three episodes (4.3%), all within three hours after initial symptom resolution. Conclusions: In this tertiary PED cohort, adrenaline administration was frequent, and biphasic reactions were uncommon and occurred during the early observation period. Given the small number of biphasic reactions, these findings should be interpreted as descriptive and are insufficient to determine the optimal observation duration.
1 January 2015 in Journal of Dr Behcet Uz Children s Hospital
Aim: Hashimoto's encephalopathy is a rare progressive and relapsing disease of presumed autoimmune origin associated with high titers of thyroid antibodies. Also named steroid-responsive encephalopathy, the disease can be cured with early treatment. Hashimoto's encephalopathy may occur with various clinical manifestations, but it often presents with symptoms such as seizures, confusion, hallucination, sleep abnormalities, and behavioural problems. Patients are mostly euthyroid or mildly hypothyroid. Hashimoto encephalopathy is a controversial diagnosis for misdiagnosis and overdiagnosis because of the high prevalence of thyroid antibodies in the population. Therefore, this diagnosis requires strict criteria that can highly indicate the diagnosis. We aimed to present the diagnosis and treatment processes from unusual symptoms of patients who are considered to have Hashimoto's encephalopathy with very strict criteria. Materials and Methods: Here we present five pediatric patients diagnosed with Hashimoto's encephalopathy between 2013 and 2023. The clinical signs and symptoms, laboratory findings, treatment options and response to treatment were obtained from patient records retrospectively. Results: On admission, patients had striking behavioural changes such as hallucinations, insomnia, purposeless laughing as well as signs of encephalopathy such as status epilepticus and confusion; neurological sequelae; history of surgery, and fever. All patients had high levels of thyroid antibodies and they responded perfectly to steroid treatment in a short period of time. Conclusion: Hashimoto’s encephalopathy should be considered in all patients presenting with encephalopathy in the pediatric age group. These patients may have unusual and clinical manifestations.